As I was saying, with respect to vaccine development and therapeutics and countermeasures, we are mobilizing Canadian scientists. We're recognizing that we need to look at ways to make sure that a lot of that development opportunity can take place here in Canada. Also, with the concept of open science, we're engaging with our international peers to look at solutions globally as well.
It's important to note that we're also focusing on building up clinical trial capacity and broad-based biomanufacturing production capabilities within Canada. These measures will enable us to make sure that we are at the forefront of engaging with other countries on vaccine development, therapeutics and other countermeasures, and also a made-in-Canada production capability in order to assist Canadians as we move forward and eventually, hopefully, find a vaccine.